See more : Sinolink Worldwide Holdings Limited (1168.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Planet 13 Holdings Inc. (PLNHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Planet 13 Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- 4imprint Group plc (FRRFF) Income Statement Analysis – Financial Results
- TNR Gold Corp. (TRRXF) Income Statement Analysis – Financial Results
- Balco Group AB (BALCO.ST) Income Statement Analysis – Financial Results
- Urals Stampings Plant PAO (URKZ.ME) Income Statement Analysis – Financial Results
- Mercury Ecommerce Acquisition Corp. (MEAC) Income Statement Analysis – Financial Results
Planet 13 Holdings Inc. (PLNHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.planet13holdings.com
About Planet 13 Holdings Inc.
Planet 13 Holdings Inc., an integrated cannabis company, engages in the cultivation, production, distribution, and marketing of cannabis and cannabis-infused products for medical and retail cannabis markets in Nevada, the United States. The company also operates licensed cannabis dispensaries; non-cannabis retail merchandise store and event space; and owns and operates Trece Eatery + Spirits, coffee shop and pizzeria. In addition, it provides consultation, education, and convenience services. The company owns and manufactures chocolates, gummies, sparkling beverages, vapes and concentrates, and flowers under the TRENDI, Leaf & Vine, Dreamland, and HaHa, and Medizin brands. Planet 13 Holdings Inc. is headquartered in Las Vegas, Nevada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 98.51M | 104.57M | 119.49M | 70.49M | 63.60M | 21.17M | 0.00 | 0.00 |
| Cost of Revenue | 53.68M | 56.60M | 53.49M | 35.12M | 27.62M | 10.31M | 0.00 | 0.00 |
| Gross Profit | 44.82M | 47.97M | 66.01M | 35.37M | 35.98M | 10.85M | 0.00 | 0.00 |
| Gross Profit Ratio | 45.50% | 45.88% | 55.24% | 50.18% | 56.57% | 51.27% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 42.42M | 52.14M | 58.58M | 25.21M | 23.56M | 11.42M | 14.80K | 10.47K |
| Selling & Marketing | 5.37M | 3.50M | 5.97M | 3.31M | 6.54M | 1.70M | 0.00 | 0.00 |
| SG&A | 47.79M | 55.64M | 64.55M | 28.51M | 30.10M | 13.12M | 14.80K | 10.47K |
| Other Expenses | 0.00 | 8.34M | 9.29M | 6.13M | 4.38M | -16.06K | 0.00 | 0.00 |
| Operating Expenses | 47.79M | 63.98M | 73.84M | 34.64M | 34.48M | 14.29M | 14.80K | 10.47K |
| Cost & Expenses | 101.47M | 120.58M | 127.33M | 69.76M | 62.10M | 24.60M | 14.80K | 10.47K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 195.72K | 454.89K | 16.98K | 1.80M | 1.31M | 241.86K | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 11.63M | 5.54M | 6.06M | 3.96M | 988.77K | 52.52K | 22.82K |
| EBITDA | -52.92M | -40.42M | -422.51K | 6.79M | 5.46M | -2.46M | -14.80K | -10.47K |
| EBITDA Ratio | -53.72% | 19.81% | -1.92% | 9.63% | 8.58% | -11.63% | 0.00% | 0.00% |
| Operating Income | -61.10M | 9.08M | -7.83M | 730.52K | 1.50M | -3.44M | -14.80K | -10.47K |
| Operating Income Ratio | -62.03% | 8.68% | -6.56% | 1.04% | 2.35% | -16.23% | 0.00% | 0.00% |
| Total Other Income/Expenses | 72.63M | -49.31M | 1.85M | -1.58M | -954.96K | -5.00M | 0.00 | 0.00 |
| Income Before Tax | 11.53M | -40.23M | -5.98M | -849.27K | 542.66K | -8.43M | -14.80K | -10.47K |
| Income Before Tax Ratio | 11.71% | -38.47% | -5.01% | -1.20% | 0.85% | -39.84% | 0.00% | 0.00% |
| Income Tax Expense | 11.53M | 8.75M | 13.48M | 7.09M | 7.20M | 2.29M | 0.00 | 0.00 |
| Net Income | 0.00 | -48.98M | -19.46M | -7.94M | -6.66M | -10.72M | -14.80K | -10.47K |
| Net Income Ratio | 0.00% | -46.84% | -16.29% | -11.27% | -10.47% | -50.66% | 0.00% | 0.00% |
| EPS | 0.00 | -0.23 | -0.10 | -0.05 | -0.05 | -0.11 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.23 | -0.10 | -0.05 | -0.05 | -0.11 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 221.96M | 216.59M | 195.13M | 151.83M | 134.07M | 96.00M | 117.24M | 117.24M |
| Weighted Avg Shares Out (Dil) | 221.96M | 216.59M | 195.13M | 151.83M | 134.07M | 96.00M | 117.24M | 117.24M |
Cannabis MSO shares rise with marijuana banking reform poised to win Senate Committee's approval
Cannabis multi-state operator (MSO) stocks are set to end another week on a high on renewed optimism around marijuana banking reform. The Senate Banking Committee is expected to hold a markup session for the Secure and Fair Enforcement (SAFE) Banking...
Planet 13 Announces Intended Completion of Change in Domicile to Nevada and Intended OTC Market and Trading Symbol Change
LAS VEGAS, NV / ACCESSWIRE / September 14, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"), a leading vertically-integrated multi-state cannabis company, today announced it intends to complete its previously announced plan of arrangement pursuant to...
Top Marijuana Stocks to Watch in Mid September 2023
In the ever-evolving landscape of the United States cannabis industry, mid-September brings excitement as investors set their sights on the top marijuana stocks. With the legal cannabis market gaining ground nationwide, staying informed about the companies poised for growth in...
Ovation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada
VANCOUVER, BC and LAS VEGAS , Sept. 11, 2023 /PRNewswire/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, today announced...
Marijuana rescheduling would be ‘life-changing event' for cannabis companies, CEOs say
The rescheduling of marijuana from a Schedule I to Schedule III drug in the United States would be transformative for the cannabis sector, CEOs of leading cannabis companies believe. Last week, the Department of Health and Human Services (HHS) made...
3 Marijuana Stocks For Cannabis Investing September 2023
Marijuana stocks could be the investment you need to make. To begin the cannabis industry is still young. Often times in an emerging industry there are a fair amount of obstacles to overcome. But there are also moments where investment...
Cannabis stock rally continues on marijuana rescheduling hopes
Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.
Cannabis stocks set to end week on a high following marijuana rescheduling recommendation
Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.
Top Marijuana Penny Stocks for September 2023
Welcome to the worldwide arena of marijuana stocks in the ever-changing cannabis sector, where the intersection of financial prospects and rising legality is creating a buzz unlike any other. As we approach September 2023, the stage is set for investors...
Planet 13 Holdings accelerates Florida expansion with $49M VidaCann acquisition
Planet 13 Holdings Inc (CSE:PLTH, OTCQX:PLNHF) said it will be acquiring private-held Florida-based cannabis cultivation, processing, transportation, fulfilment and storage, and dispensing company VidaCann for total consideration of approximately US$48.9 million to accelerate its Florida expansion strategy. The company said...
Source: https://incomestatements.info
Category: Stock Reports